New Research: Hysterectomy Increases Stroke Risk by Up to 18 Percent
Dato Capt. Mahesan Subramaniam, Co-Founder of United Health Tourism, shared a post on LinkedIn:
”New research shows that removing the uterus – and especially both ovaries – can come with serious long-term health consequences.
A large meta-analysis of over 2 million people found that women who undergo a hysterectomy have a 5 percent higher risk of stroke, while those who also have both ovaries removed face an 18 percent higher risk. The ovaries produce hormones that help regulate cardiovascular health, and their removal can trigger premature menopause, which may partially explain the increased stroke risk.
Hysterectomy and oophorectomy are common procedures in the US, often performed for conditions like fibroids, endometriosis, prolapse, or cancer.
Historically, removing both ovaries during hysterectomy was more common, but newer evidence suggests this practice carries significant risks for heart and brain health.
Studies show that age at surgery, hormone replacement therapy, and individual health factors influence stroke risk, meaning careful patient assessment is essential before surgery.
Research Paper here”
Title: Stroke risk in women with or without hysterectomy and/or bilateral oophorectomy: evidence from the NHANES 1999-2018 and meta-analysis
Authors: Chuan Shao, Chao Xu, Dewei Zou, Gang Zhang, Haotian Jiang, Cheng Zeng, Tao Tang, Hui Tang, Nan Wu
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 05:42Subramamyam Penubaku: Early Recognition and Risk-Based Management of Acute Pulmonary Embolism
-
Jun 4, 2026, 05:30Raghavendra Rao: Early Endothermal Ablation and Contemporary Management of Superficial Venous Thrombosis
-
Jun 4, 2026, 05:18Fouad Mikhail: Mechanical Thrombectomy and Anticoagulation in Intermediate-Risk Pulmonary Embolism
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity